Product Images Guanfacine Extended-release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Guanfacine Extended-release NDC 60429-961 by Golden State Medical Supply, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
60429 960 01OL
This is a description for Guanfacine, an extended-release tablet produced by GSMS Incorporated that contains 1.14mg of guanfacine hydrochloride equivalent to 1mg guanfacine. The tablets come in a package of 100 and should be stored in a container that is tight and light-resistant. The tablets should not be chewed, crushed, or broken before swallowing. The medication should be kept out of reach of children. Information about the dosage can be found in the package insert. The manufacturer is TWi Pharmaceuticals, Inc, and the tablets are packaged by GSMS Incorporated in Camarillo, CA.*
60429 961 01
This is a description for Guanfacine, an extended-release tablet manufactured by TWi Pharmaceuticals, Inc. and packaged by GSMS, Incorporated. It contains 2mg of guanfacine hydrochloride, which should not be crushed, chewed, or broken before swallowing. The tablets come in a package of 100 and should be stored at 20° to 25°C (88° to 77°F). For dosage instructions, see the package insert. The label also contains the NDC number, dosage strength, and warnings about keeping the medication out of the reach of children and dispensing in a tight, light-resistant container.*
60429 962 01OL
This is a description of Guanfacine extended-release tablets manufactured by TW1 Pharmaceuticals, Inc. and packaged by GSMS, Inc. The tablets contain 3 mg guanfacine hydrochloride and are not to be crushed, chewed, or broken before swallowing. The medication should be dispensed in a tight, light-resistant container and kept out of the reach of children. The package insert should be consulted for dosage instructions.*
60429 963 01OL
This is a description for Guanfacine extended-release tablets, manufactured by TWI Pharmaceuticals, Inc. and packaged by GSMS Incorporated. The tablets come in a bottle of 100 and are not safe for children. The package insert should be consulted for dosage information, and the tablets should not be crushed, chewed, or broken before swallowing. The pharmacist should dispense this medicine with an attached patient information leaflet in a tight, light-resistant container. The tablets contain 4.56 mg of guanfacine hydrochloride equivalent to 4 mg guanfacine. It is recommended to store at 20-25°C.*
figure-1.jpg - figure 1
figure-2.jpg - figure 2
figure-3.jpg - figure 3
figure-4.jpg - figure 4
figure-5 - figure 5
molecular-structure.jpg - molecular structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.